US Stock MarketDetailed Quotes
TBIO TELESIS BIO
- 3.800
- -0.130-3.31%
Close Sep 10 16:00 ET
- 1.650
- -2.150-56.58%
Post 19:59 ET
6.74MMarket Cap-126P/E (TTM)
3.976High3.780Low61.90KVolume3.810Open3.930Pre Close143.40KTurnover10.11%Turnover RatioLossP/E (Static)1.77MShares23.45952wk High-0.33P/B2.33MFloat Cap3.02552wk Low--Dividend TTM612.11KShs Float462.600Historical High--Div YieldTTM4.98%Amplitude3.025Historical Low2.316Avg Price1Lot Size
TELESIS BIO Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -77.87%1.55M | -45.54%3.44M | 0.27%27.51M | -26.32%6.98M | -16.64%5.56M | 23.85%7M | 12.07%6.32M | 148.44%27.44M | 207.63%9.47M | 139.59%6.68M |
| Operating revenue | -77.87%1.55M | -45.54%3.44M | 0.27%27.51M | -26.32%6.98M | -16.64%5.56M | 23.85%7M | 12.07%6.32M | 148.44%27.44M | 207.63%9.47M | 139.59%6.68M |
| Cost of revenue | 15.20%2.35M | -28.91%1.99M | -10.82%10.56M | -26.30%2.23M | -14.89%2.57M | -30.72%2.04M | -1.85%2.81M | 75.56%11.84M | 37.66%3.02M | 85.71%3.02M |
| Gross profit | -116.09%-799K | -58.82%1.45M | 8.69%16.95M | -26.33%4.75M | -18.09%3M | 83.08%4.97M | 26.39%3.51M | 262.76%15.6M | 630.84%6.45M | 214.89%3.66M |
| Operating expense | -22.02%9.68M | -31.18%9.97M | -16.08%52.1M | -24.35%10.84M | -12.02%13.12M | -27.86%12.41M | -7.41%14.48M | 56.48%62.08M | 10.41%14.33M | 40.62%14.91M |
| Selling and administrative expenses | -15.10%7.21M | -24.77%7.04M | -10.40%34.6M | -25.76%7.17M | -4.77%9M | -17.20%8.49M | 0.27%9.36M | 53.21%38.62M | 24.98%9.66M | 34.81%9.45M |
| -Selling and marketing expense | -46.80%1.7M | -56.00%1.68M | -18.04%13.51M | -13.18%3.6M | -34.52%2.74M | -29.97%3.19M | 7.36%3.81M | 50.47%16.49M | 34.90%4.15M | 41.76%4.19M |
| -General and administrative expense | 4.02%5.51M | -3.37%5.37M | -4.70%21.09M | -35.25%3.57M | 18.91%6.26M | -6.98%5.29M | -4.08%5.55M | 55.32%22.13M | 18.42%5.51M | 29.74%5.26M |
| Research and development costs | -37.01%2.47M | -42.88%2.93M | -25.42%17.5M | -21.42%3.67M | -24.56%4.12M | -43.58%3.92M | -18.78%5.12M | 62.17%23.46M | -11.05%4.67M | 51.96%5.46M |
| Operating profit | -40.74%-10.47M | 22.33%-8.52M | 24.38%-35.15M | 22.73%-6.09M | 10.04%-10.12M | 48.63%-7.44M | 14.71%-10.97M | -31.41%-46.49M | 34.83%-7.88M | -19.17%-11.25M |
| Net non-operating interest income expense | 83.78%-54K | 104.42%11K | -11.91%-1.36M | 63.12%-97K | -114.11%-683K | -11.37%-333K | 25.89%-249K | 11.10%-1.22M | 28.53%-263K | 16.27%-319K |
| Non-operating interest income | -57.22%160K | -41.54%228K | 136.18%1.74M | ---- | ---- | --374K | --390K | --738K | ---- | ---- |
| Non-operating interest expense | -69.73%214K | -66.04%217K | 58.82%3.11M | 83.82%1.84M | 114.11%683K | 136.45%707K | 90.18%639K | 42.80%1.96M | 172.01%1M | -16.27%319K |
| Other net income (expense) | -6,550.00%-1.03M | -220.19%-125K | -1,401.74%-11.19M | -54,838.10%-11.5M | 125.34%187K | 141.03%16K | 845.45%104K | 66.15%-745K | 195.45%21K | -37,000.00%-738K |
| Gain on sale of security | ---- | ---- | 4,037.50%331K | -82.76%5K | 1,082.35%167K | 170.37%19K | 508.70%140K | 100.53%8K | 163.64%29K | -213.33%-17K |
| Special income (charges) | ---1.02M | ---- | -1,466.57%-11.39M | ---11.39M | --0 | --0 | ---- | -17.64%-727K | --0 | ---727K |
| -Less:Impairment of capital assets | --1.02M | ---- | --11.39M | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.64%727K | --0 | --727K |
| Other non- operating income (expenses) | -400.00%-15K | -247.22%-125K | -400.00%-130K | -1,287.50%-111K | 233.33%20K | 75.00%-3K | -200.00%-36K | 58.06%-26K | 75.76%-8K | 146.15%6K |
| Income before tax | -48.99%-11.56M | 22.32%-8.64M | 1.54%-47.7M | -117.62%-17.68M | 13.74%-10.62M | 47.66%-7.76M | 15.71%-11.12M | -24.40%-48.45M | 34.92%-8.13M | -25.34%-12.31M |
| Income tax | -75.00%1K | -33.33%2K | 0.00%24K | -50.00%3K | 133.33%14K | -33.33%4K | -50.00%3K | 71.43%24K | 50.00%6K | 50.00%6K |
| Net income | -51.86%-12.59M | 22.32%-8.64M | 1.54%-47.72M | -117.50%-17.69M | 13.67%-10.63M | 44.12%-8.29M | 15.73%-11.12M | -24.42%-48.47M | 34.90%-8.13M | -25.35%-12.31M |
| Net income continuous Operations | -48.92%-11.56M | 22.32%-8.64M | 1.54%-47.72M | -117.50%-17.69M | 13.67%-10.63M | 47.66%-7.76M | 15.73%-11.12M | -24.42%-48.47M | 34.90%-8.13M | -25.35%-12.31M |
| Net income discontinuous operations | -95.42%-1.02M | ---- | ---- | ---- | ---- | ---524K | ---- | ---- | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -51.86%-12.59M | 22.32%-8.64M | 1.54%-47.72M | -117.50%-17.69M | 13.67%-10.63M | 44.12%-8.29M | 15.73%-11.12M | -24.42%-48.47M | 34.90%-8.13M | -25.35%-12.31M |
| Preferred stock dividends | 289.54%596K | 585K | 1.3M | 579K | 568K | 153K | ||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -56.17%-13.18M | 17.06%-9.22M | -1.14%-49.02M | -124.62%-18.27M | 9.05%-11.2M | 43.09%-8.44M | 15.73%-11.12M | -24.42%-48.47M | 34.90%-8.13M | -25.35%-12.31M |
| Basic earnings per share | -49.41%-7.62 | 18.22%-5.52 | 0.61%-29.52 | -117.86%-10.98 | 11.90%-6.66 | 43.33%-5.1 | 16.67%-6.75 | 22.90%-29.7 | 34.28%-5.04 | -23.53%-7.56 |
| Diluted earnings per share | -49.41%-7.62 | 18.22%-5.52 | 0.61%-29.52 | -117.86%-10.98 | 11.90%-6.66 | 43.33%-5.1 | 16.67%-6.75 | 22.90%-29.7 | 34.28%-5.04 | -23.53%-7.56 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg